126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands.
Beeson
David
D
Neurosciences Group, Weatherall Institute of Molecular Medicine, The John Radcliff, Oxford, UK.
Hantaï
Daniel
D
Lochmüller
Hanns
H
Engel
Andrew G
AG
D002795:Choline O-Acetyltransferase / Q000235:genetics; D005838:Genotype; D006801:Humans; D008967:Molecular Biology / Q000379:methods; D009124:Muscle Proteins / Q000235:genetics; D009154:Mutation; D020294:Myasthenic Syndromes, Congenital / Q000145:classification / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D009426:Netherlands; D009469:Neuromuscular Junction / Q000502:physiology; D010641:Phenotype; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics; D011950:Receptors, Cholinergic / Q000235:genetics; D015222:Sodium Channels / Q000235:genetics
D009124:Muscle Proteins; D011950:Receptors, Cholinergic; D015222:Sodium Channels; C051609:peripheral membrane protein 43K; D002795:Choline O-Acetyltransferase; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases